What You Should Know:
- In May, U.S. hospitals, health systems, and physician groups were beginning to recover from COVID-19’s impact on their operations, but the dramatic spread of the Delta variant and an increase in COVID-19 cases and hospitalizations caused new setbacks, according to two reports from Kaufman Hall.
- Hospitals and health systems experienced setbacks in July as the variant drove dramatic spikes in new COVID-19 cases and hospitalizations. Margins and volumes both fell
Read More
Connect America Acquires Remote Patient Monitoring Platform 100Plus
What You Should Know:
- Connect America LLC, a provider of digital health and connected care for seniors and vulnerable populations, today announced it has signed a definitive agreement to acquire 100Plus, the remote patient monitoring (RPM) platform that uses artificial intelligence (AI).
- Connect America, a portfolio company of Detroit-based Rockbridge Growth Equity, is adding complimentary digital health products and technologies to enable both passive monitoring of patients in
Read More
AllStripes Secures $50M to Advance Global Rare Disease Research Platform
- AllStripes, a San Francisco-based healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced it has raised $50 million in Series B funding led by Lux Capital, a current investor, joined by JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, and Maveron. The round also included participation from angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director
Read More
UPMC Launches Drug Discovery Company Novasenta to Develop Targeted Immunotherapy Drugs for Cancer
What You Should Know:
- UPMC today announced the launch of Novasenta, a drug discovery and development company seeking novel and effective treatments for cancer. Co-founded in late 2018 by Robert Ferris, M.D., Ph.D., Dario Vignali, Ph.D., and Greg Delgoffe, Ph.D., all of the UPMC Hillman Cancer Center and Pitt, Novasenta is currently focused on T-cell targets and rapidly advancing programs with the goal of launching its first clinical trial by the end of 2023.
- Based on years
Read More
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative
What You Should Know:
- Optellum, a lung-health medtech startup that is pioneering the use of AI to improve diagnostic accuracy and clinical decision-making announce a strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative. This announcement accelerates Optellum’s market entry, building on its FDA clearance earlier this year and deployments underway at hospitals in the USA and ongoing clinical trials in the United Kingdom.
- As part of the collaboration, Optellum will
Read More
Provider Adoption of Automated Revenue Cycle Operations On The Rise
What You Should Know:
- 78 percent of health systems are currently using or are in the process of implementing automation in their revenue cycle operations, according to recent survey results from AKASA, a South San Francisco-based revenue cycle management automation company. The key findings signal automation in healthcare is no longer an emerging trend but is mission-critical for driving efficiency and cost-effectiveness in revenue cycle operations.
- According to the
Read More
MiSalud Launches Digital Health and Wellness Platform for the Underserved US Hispanic Community
What You Should Know:
- MiSalud Inc., a San Francisco-based digital health startup has raised $5M and is launching the beta version of their digital health and wellness platform led by Pivotal Ventures, a Melinda French Gates company, with Magnify Ventures. MiSalud, which means My Health in Spanish, aims to make healthcare more inclusive by offering personalized healthcare services to US Hispanics through its mobile app and platform.
- MiSalud offers a unique combination of personalized
Read More
TRIPP Acquires PsyAssist to Support Patients with VR-Powered Psychedelic Therapy
TRIPP, the fastest-growing digital psychedelics platform today acquired PsyAssist to commercialize a first-of-its-kind offering that supports the psychological healing journey of patients in psychedelic-assisted therapies. Financial details of the acquisition were not disclosed.
The acquisition will empower psychotherapists and patients to safely and effectively use TRIPP’s VR, AR, and mobile experiences for ketamine-assisted therapy, and clinical trials of MDMA, and psilocybin
Read More
Geisinger Unveils AI-Backed, Customizable Approach to Medical Billing
What You Should Know:
- Today, Geisinger announced a new AI-backed, customizable approach to medical billing where patients have the power to select zero-interest payment plans that that can be paid over a timeline of their choosing.
- The new offering in partnership with fintech startup, PayZen marks Geisinger as the first large health system in the country to deploy an AI-backed financing solution to create customized billing solutions that will help patients more easily afford
Read More
Cerner Appoints Dr. David Feinberg as New President & CEO
What You Should Know:
Today, Cerner announced that its Board of Directors has appointed Dr. David Feinberg as its new President and Chief Executive Officer, effective Oct. 1. Dr. Feinberg succeeds Brent Shafer, who previously announced his decision to transition from chairman and CEO.
- Dr. Feinberg will serve as a member of the Board of Directors. Cerner’s current President, Donald Trigg, will leave Cerner. Cerner’s Board of Directors also announced that it will separate the roles of
Read More
